The protective action of topiramate on dopaminergic neurons.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Medical Science Monitor

• Publication date

  2010-08-07

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 20802407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• From the basics to application of cell therapy, a steppingstone to the conquest of neurodegeneration: a meeting report.

  2009cited by this paper
• Can we achieve neuroprotection with currently available anti-parkinsonian interventions?

  2009cited by this paper
• Differences in WHOQOL-100 domain scores in Parkinson's disease and osteoarthritis.

  2008cited by this paper
• Time-Course of Brain Oxidative Damage Caused by Intrastriatal Administration of 6-Hydroxydopamine in a Rat Model of Parkinson’s Disease

  2006cited by this paper
• Topiramate monotherapy in epilepsy and migraine prevention.

  2005cited by this paper
• Effect of topiramate on the kainate-induced status epilepticus, lipid peroxidation and immunoreactivity of rats.

  2004cited by this paper
• Topiramate Extends the Therapeutic Window for Hypothermia-Mediated Neuroprotection After Stroke in Neonatal Rats

  2004cited by this paper
• Modulation by Topiramate of AMPA and Kainate Mediated Calcium Influx in Cultured Cerebral Cortical, Hippocampal and Cerebellar Neurons

  2004cited by this paper
• Prevalence, etiology, and treatment of depression in Parkinson's disease.

  2003cited by this paper
• A pooled analysis of adjunctive topiramate in refractory partial epilepsy

  2003cited by this paper
• Novel Mechanisms of Action of Three Antiepileptic Drugs, Vigabatrin, Tiagabine, and Topiramate

  2003cited by this paper
• Antiischemic Effects of Topiramate in a Transient Global Forebrain Ischemia Model: A Neurochemical, Histological, and Behavioral Evaluation

  2003cited by this paper
• Pitx3 is required for development of substantia nigra dopaminergic neurons

  2003cited by this paper
• Topiramate protects against motor neuron degeneration in organotypic spinal cord cultures but not in G93A SOD1 transgenic mice.

  2003cited by this paper
• Pergolide protects dopaminergic neurons in primary culture under stress conditions

  2002cited by this paper
• Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration.

  2001cited by this paper
• Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils.

  2000cited by this paper
• Modulation of High‐Voltage–Activated Calcium Channels in Dentate Granule Cells by Topiramate

  2000cited by this paper
• Topiramate Modulates GABA‐Evoked Currents in Murine Cortical Neurons by a Nonbenzodiazepine Mechanism

  2000cited by this paper
• Topiramate reduces neuronal injury after experimental status epilepticus.

  1999cited by this paper
• Safety of Topiramate: Adverse Events and Relationships to Dosing

  1996cited by this paper
• Different mechanisms of glutamate‐induced neuronal death between dopaminergic and non‐dopaminergic neurons in rat mesencephalic culture

  1996cited by this paper
• l‐DOPA Up‐Regulates Glutathione and Protects Mesencephalic Cultures Against Oxidative Stress

  1996cited by this paper

• DRD4 Interacts with TGF‐β Receptors to Drive Colorectal Cancer Metastasis Independently of Dopamine Signaling Pathway

  2024cites this paper
• Neuroleptic Malignant Syndrome From Oxcarbazepine and Topiramate Withdrawal: An Unusual Case

  2022cites this paper
• Influence of Topiramate on the Synaptic Endings of the Temporal Lobe Neocortex in an Experimental Model of Hyperthermia-Induced Seizures: An Ultrastructural Study

  2021cites this paper
• Effects of topiramate on the ultrastructure of synaptic endings in the hippocampal CA1 and CA3 sectors in the rat experimental model of febrile seizures: the first electron microscopy report.

  2019cites this paper
• Homocysteine and Apoptotic Factors in Epileptic Patients Treated with Anti-Epileptic Drugs

  2014cites this paper
• Targeted D4 dopamine receptors: implications for drug discovery and therapeutic development.

  2013cites this paper
• What’s the role of topiramate in the management of patients with hyperkinetic movement disorders?

  2012cites this paper
• What ’ s the role of topiramate in the management of patients with hyperkinetic movement disorders ?

  2012cites this paper
• Classical neurotransmitters and neuropeptides involved in generalized epilepsy: a focus on antiepileptic drugs.

  2011cites this paper
• The neuroprotective effect of topiramate on the ultrastructure of pyramidal neurons of the hippocampal CA1 and CA3 sectors in an experimental model of febrile seizures in rats.

  2011cites this paper
• Theneuroprotectiveeffectoftopiramateontheultrastructure ofpyramidalneuronsofthehippocampalCA1andCA3sectors inanexperimentalmodeloffebrileseizuresinrats

  2011cites this paper
• Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders

  2011cites this paper